Fertility Preservation Consult
What code are we supposed to use for counseling regarding fertility preservation for an individual with cancer, or for fertility preservation not related to cancer treatment or before a gonadectomy? In addition, after the consult, if a patient chooses to go through an IVF cycle with oocyte or embryo cryopreservation, what diagnosis should be used?
Login now to view this Coding information. Coding Resources are available to ASRM Members only.
If you are not an ASRM member and would like to be, visit the Membership Tab above.
Coding Q&A
View more Coding Q&A in this category
How to Bill to Insurance When Treatment Cycle is Canceled
If a patient is self-paying for treatment and the patient’s IVF or FET cycle is canceled, what would be the appropriate code to use to send
How to Code for Surgical Tubal Anastomosis
How do you properly code this surgical tubal anastomosis and chromotubation? In this case, codes 58679 and 58662 were billed
Billing Same Sex Male Donor Cycles
If both male partners provide sperm for the fertilization process, would we obtain authorization/bill for the fertilization process for
Correct Code to use for using Zymot to Prepare Sperm for Insemination
We recently started using ZyMot to prepare sperm for insemination. Is 89260 the correct CPT code to use? Do youCoding Corner
Coding Corner is segmented into the following sections. Click an image below to view questions and answers in that section.
More Resources
ASRM Practice Documents
These guidelines have been developed by the ASRM Practice Committee to assist physicians with clinical decisions regarding the care of their patients.
ASRM Academy on the Go
ASRM MAC Tool 2021
The ASRM Müllerian Anomaly Classification 2021 (MAC2021) includes cervical and vaginal anomalies and standardize terminology within an interactive tool format.
Practice Guidance
Coding Corner Q & A
The Coding Corner Q & A is a list of previously submitted and answered questions from ASRM members about coding. Answers are available to ASRM Members only.
Practice Guidance
EMR Shared Phrases/Template Library
This resource includes phrases shared by ASRM physician members to provide a template for individuals to create their own EMR phrases.
ASRM Ethics Opinions
Ethics Committee Reports are drafted by the members of the ASRM Ethics Committee on the tough ethical dilemmas of reproductive medicine.
Practice Guidance
COVID-19 Resources
A compendium of ASRM resources concerning the Novel Corona virus (SARS-COV-2) and COVID-19.
Patient Resources
ReproductiveFacts.org provides a wide range of information related to reproductive health and infertility through patient education fact sheets, infographics, videos, and other resources.
Topic Resources
View more on the topic of cancer and fertility
Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
New ASRM‑supported research highlights key IVF and fertility preservation access needs for cancer patients — particularly during Breast Cancer Awareness Month. View the Press Release
Fertility drugs and cancer: a guideline (2024)
Methodological limitations in studying the association between the use of fertility drugs and cancer include the inherent increased risk of cancer in women who never conceive. View the Committee Guideline
Medication Administration
Is CPT code 96402 applicable to a Depo-Lupron or Zoladex injection by nurse at REI practice, even if there is no diagnosis of cancer? View the Answer
Fertility Preservation Consult
What code are we supposed to use for counseling regarding fertility preservation for an individual with cancer... View the Answer
D&C Under Ultrasound Guidance
What are the CPT codes and ICD-10 codes for coding a surgical case for a patient with history of Stage B adenocarcinoma of the cervix ... View the Answer
Cycle Monitoring Fertility Preservation
If the patient is undergoing ultrasound tracking visits for fertility preservation, what I ICD-10 code do you use for the monitoring? View the Answer
Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review (2019)
Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions. View the Joint Statement
Best practices of ASRM and ESHRE: a journey through reproductive medicine (2012)
ASRM and ESHRE are the two largest societies in the world whose members comprise the major experts and professionals working in reproductive medicine. View the Committee Joint GuidelineTopic Resources
View more on the topic of fertility preservation
Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
New ASRM‑supported research highlights key IVF and fertility preservation access needs for cancer patients — particularly during Breast Cancer Awareness Month. View the Press Release
Fertility and Sterility On Air - Unplugged: October 2025
Circadian rhythms, bariatric surgery, IL‑22, and mTOR’s role in fertility—hear expert insights in ASRM’s latest Fertility & Sterility Unplugged episode. Listen to the Episode
Fertility and Sterility On Air - Roundtable: Egg Sharing
Experts debate the ethics of egg sharing and split cycles, exploring patient autonomy, informed consent, diversity, and equitable fertility care. Listen to the Episode
The Heart of Advocacy Day
Advocacy is a commitment to push through discomfort for the sake of future progress. Learn more about RESOLVE's Advocacy Day in partnership with ASRM.
Fertility and Sterility On Air - Best of ASRM and ESHRE 2025
Experts explore recurrent pregnancy loss, embryo testing, IVF mental health, and stem cell banking at ASRM–ESHRE 2025. Insights from leading fertility voices. Listen to the Episode
Oocyte cryopreservation
We code 89337 (cryopreservation of oocytes) for the entire oocyte preservation cycle, including monitoring visits. View the Answer
Reimplantation of cryopreserved ovarian tissue
What is the correct code for laparoscopic reimplantation of ovarian tissue? View the Answer
Planned oocyte cryopreservation to preserve future reproductive potential: an Ethics Committee opinion (2023)
Planned oocyte cryopreservation is an ethically permissible procedure that may help individuals avoid future infertility. View the Committee Opinion
Z Codes Vs. Procedure Codes For Fertility Preservation Counseling
I am trying to understand better when to use the procreative management code vs the fertility preservation counseling and procedure codes. View the Answer
Elective fertility preservation is ART
From an insurance standpoint, is fertility preservation is considered an assisted reproductive technology or would it be branched under other? View the Answer
Oocyte Preservation Consult
Our center performs oocyte preservation procedures for women looking to preserve their fertility. View the Answer
Fertility Preservation Consult
What code are we supposed to use for counseling regarding fertility preservation for an individual with cancer... View the Answer
Coding For Ovarian Tissue Cryopreservation
Now that ASRM has removed the "experimental" designation from ovarian tissue cryopreservation what CPT code should be used instead of 0058T? View the Answer
Cycle Monitoring Fertility Preservation
If the patient is undergoing ultrasound tracking visits for fertility preservation, what I ICD-10 code do you use for the monitoring? View the Answer
Access to fertility services by transgender and nonbinary persons: an Ethics Committee opinion (2021)
The provision of fertility services to transgender individuals and the denial of access to fertility services is not justified. View the Committee Opinion
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion (2019)
Expert guidelines on fertility preservation options—oocyte, embryo, ovarian and testicular tissue cryopreservation and counseling before gonadotoxic treatment. View the Committee Opinion
Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review (2019)
Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions. View the Joint Statement
Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion (2018)
Patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. View the Committee Opinion
